Celestica's stock was soaring 6.35% during intraday trading on Thursday, marking a significant recovery.
The surge follows a major analyst upgrade, with Bofa Global Research raising its price objective for the company to $490 from $430, boosting investor confidence in the stock's future performance.
This upward movement also represents a continued technical rebound. The stock had experienced a sharp selloff earlier in the week after the company's first-quarter earnings report, which, despite beating expectations, fell short of the market's elevated hopes for its AI-related business segments.